Moreover, CD38 deficiency regulated microglia activation through microglia-associated mechanisms to attenuate glioma progression, and it could modulate tumor-associated microglia/macrophage characteristics (16), which was also consistent with our study. This evidence concerns the gene CD38 and neoplasm.